NYSE - Delayed Quote USD

Colgate-Palmolive Company (CL)

Compare
98.08 +0.07 (+0.07%)
At close: July 19 at 4:00 PM EDT
99.07 +0.99 (+1.01%)
After hours: July 19 at 7:51 PM EDT
Loading Chart for CL
DELL
  • Previous Close 98.01
  • Open 99.03
  • Bid 96.50 x 1400
  • Ask 98.28 x 800
  • Day's Range 97.65 - 99.07
  • 52 Week Range 67.62 - 99.63
  • Volume 4,228,180
  • Avg. Volume 4,153,311
  • Market Cap (intraday) 80.469B
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) 31.14
  • EPS (TTM) 3.15
  • Earnings Date Jul 26, 2024
  • Forward Dividend & Yield 2.00 (2.03%)
  • Ex-Dividend Date Jul 19, 2024
  • 1y Target Est 100.61

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

www.colgatepalmolive.com

34,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CL

View More

Related Videos: CL

Performance Overview: CL

Trailing total returns as of 7/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CL
24.50%
S&P 500
15.41%

1-Year Return

CL
32.55%
S&P 500
20.86%

3-Year Return

CL
24.97%
S&P 500
27.22%

5-Year Return

CL
48.72%
S&P 500
83.80%

Compare To: CL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CL

View More

Valuation Measures

Annual
As of 7/18/2024
  • Market Cap

    80.82B

  • Enterprise Value

    88.43B

  • Trailing P/E

    31.27

  • Forward P/E

    28.17

  • PEG Ratio (5yr expected)

    2.41

  • Price/Sales (ttm)

    4.13

  • Price/Book (mrq)

    351.40

  • Enterprise Value/Revenue

    4.48

  • Enterprise Value/EBITDA

    20.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.22%

  • Return on Assets (ttm)

    15.71%

  • Return on Equity (ttm)

    531.67%

  • Revenue (ttm)

    19.75B

  • Net Income Avi to Common (ttm)

    2.61B

  • Diluted EPS (ttm)

    3.15

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.31B

  • Total Debt/Equity (mrq)

    1,408.27%

  • Levered Free Cash Flow (ttm)

    2.8B

Research Analysis: CL

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

80.00 Low
100.61 Average
98.08 Current
114.00 High
 

Company Insights: CL

Research Reports: CL

View More
  • The Argus Min Vol Model Portfolio

    Rapidly rising inflation in 2022 knocked stocks into a bear market. While growth strategies suffered the most, value strategies also declined. Even bond prices were lower that year. Stocks have recovered and a new bull market has started, but gains have been largely driven by only a handful of high-tech companies. Inflation remains an issue and the Federal Reserve has yet to lower rates. Is a recession in the offing? With all the uncertainty, what's a potential equity strategy for investors amid all the uncertainty? Argus believes that Min Vol is an all-weather strategy that is timely in any investing climate. Academic literature and, more to the point, returns history, indicate that Min Vol can deliver market-matching returns on an absolute basis and superior returns on a risk-adjusted basis over various time periods.

     
  • The Argus Min Vol Model Portfolio

    Rapidly rising inflation in 2022 knocked stocks into a bear market. While growth strategies suffered the most, value strategies also declined. Even bond prices were lower that year. Stocks have recovered and a new bull market has started, but gains have been largely driven by only a handful of high-tech companies. Inflation remains an issue and the Federal Reserve has yet to lower rates. Is a recession in the offing? With all the uncertainty, what's a potential equity strategy for investors amid all the uncertainty? Argus believes that Min Vol is an all-weather strategy that is timely in any investing climate. Academic literature and, more to the point, returns history, indicate that Min Vol can deliver market-matching returns on an absolute basis and superior returns on a risk-adjusted basis over various time periods.

     
  • Raising target price

    Colgate-Palmolive, based in New York, manufactures and distributes consumer products in the following categories: oral care, personal care, household surface care, fabric care, and pet food. The company's brands include Colgate, Palmolive, Irish Spring, Softsoap, Ajax, Fab, Protex (antibacterial soap), and Hill's Science Diet pet food. The company's products are sold in more than 200 countries. The company has approximately 34,000 employees. The shares are a component of the S&P 500.

    Rating
    Price Target
     
  • The technical scorecard for stocks remains bullish, as indices at new all-time

    The technical scorecard for stocks remains bullish, as indices at new all-time highs (and others missing by only a few points) are actually lagging advance/decline lines that have led price to new highs. Historically, when market breadth leads price, it has been bullish when looking out six to 12 months.

     

People Also Watch